Brief: Ardelyx Announces Publication Of Positive Results From T3mpo-3 Long-Term Open-Label Safety Trial Of Tenapanor

Ardelyx

28/09/2023 13:11

Sept 28 (Reuters) - Ardelyx Inc  ARDX.O :
    * ARDELYX ANNOUNCES PUBLICATION OF POSITIVE RESULTS FROM
T3MPO-3
LONG-TERM OPEN-LABEL SAFETY TRIAL OF TENAPANOR FOR IBS-C IN THE
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY
    * ARDELYX INC - TENAPANOR SHOWED ACCEPTABLE TOLERABILITY
WITH A
SAFETY PROFILE CONSISTENT WITH THAT REPORTED IN PRIOR STUDIES
    * ARDELYX INC - TENAPANOR WAS GENERALLY WELL TOLERATED WITH
DIARRHEA BEING MOST COMMONLY REPORTED ADVERSE EVENT

Source text for Eikon:  ID:nGNX3DBYZ1 
Further company coverage:  ARDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))